Latest stories on INSM
H.C. Wainwright reiterates Insmed stock rating on pipeline progress
Investing.com Analyst Ratings53 · neutralanalyst
C4 Therapeutics (CCCC) Rises as Its CFO Is Named to Insmed’s Board in High-Profile Director Appointments
October 20, 2026
MarketChameleon58 · neutralgeneral
Insmed price target lowered to $173 from $187 at Raymond James
The Fly34 · bearishanalyst
Insmed Strengthens Board With New Independent Directors
TipRanks56 · neutralgeneral
INSMED Inc (INSM) files 8-K
SEC 8-K50 · neutralgeneral
Insmed Appoints Two New Directors to Its Board
StockTitan52 · neutralgeneral
Insmed’s BRINSUPRI launch in Japan makes it the only commercially available NCFB therapy in the country
October 19, 2026
MarketChameleon64 · neutralproduct/pr
Insmed Launches BRINSUPRI® Tablets 25 mg (brensocatib hydrate) for the Treatment of Non-Cystic Fibrosis Bronchiectasis in Japan
PR Newswire63 · neutralproduct/pr
Insmed to Present New Data Across Its Respiratory Portfolio at CHEST 2026 and IDWeek 2026
PR Newswire58 · neutralproduct/pr
Truist previews biotech earnings with focus on Insmed, BridgeBio
Investing.com Analyst Ratings55 · neutralanalyst
BofA cuts Insmed stock price target on valuation concerns
Investing.com Analyst Ratings34 · bearishanalyst
Insmed downgraded to Peer Perform from Outperform at Wolfe Research
The Fly34 · bearishanalyst
BMO Capital reiterates Insmed stock rating on CFO transition
Investing.com Analyst Ratings50 · neutralgeneral
Insmed Sets CFO Exit Date as It Reaffirms 2026 Revenue Guidance for BRINSUPRI and ARIKAYCE
October 5, 2026
MarketChameleon56 · neutralgeneral
Insmed stock falls as CFO Sara Bonstein to step down
Investing.com Markets38 · neutralgeneral
Insmed CFO Sara Bonstein to step down, reaffirms guidance
Seeking Alpha50 · neutralgeneral
Insmed (INSM) CFO to Step Down After Nearly Seven Years as Company Reaffirms 2026 Revenue Guidance
October 5, 2026
MarketChameleon53 · neutralgeneral
Insmed backs FY26 brinsupri revenue view $1.25B-$1.4B
The Fly63 · neutralearnings
Insmed announces CFO Sara Bonstein to step down
The Fly47 · neutralgeneral
INSMED Inc (INSM) files 8-K
SEC 8-K50 · neutralgeneral
Insmed Announces CFO Transition
PR Newswire50 · neutralgeneral
Final Trade: MCD, INSM, GOOGL, NET
CNBC50 · neutralgeneral
Insmed price target lowered to $207 from $237 at Barclays
The Fly38 · neutralanalyst
3 Healthcare Stocks Showing Why the Sector Still Has Momentum
MarketBeat64 · neutralearnings